IRADIMED CORP
IRMDNASDAQTrading Snapshot
- Day Range
- $83.56 – $85.03
- 52-Week Range
- $75.75 – $107.90
- Volume (shares)
- 161,626
- Avg Volume (shares)
- —
- Shares Outstanding
- 12.8M
- Next Earnings
- 2026-10-30
Fundamentals Snapshot
- Annual Revenue
- $84M
- Last Q Revenue
- $20M
- P/E Ratio
- 46.6
- P/S Ratio
- 12.4x
- EPS (TTM)
- $1.79
- Dividend Yield
- 1.47%
- Dilution (1yr)
- +0.7%
IRADIMED CORP
IRMD
StockOtter · stockotter.spaceAbout IRADIMED CORP
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Latest News & Updates
Riverwater Small Cap Strategy Q3 2026 Portfolio Update
During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors include AtriCure and Red Vi
iRadimed (IRMD) Expected to Post Earnings on Friday
iRadimed (NASDAQ: IRMD - Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Friday, October 30th. Analysts expect the company to announce earnings of $0.55 per share and revenue of
IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026
ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on Friday, October 30, 2
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
ORLANDO, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it wi
Head-To-Head Contrast: iRadimed (NASDAQ:IRMD) & Medline (NASDAQ:MDLN)
iRadimed (NASDAQ: IRMD - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100
On September 04, 2026, iRadimed Corp (IRMD) shares fell 3.8%, currently trading at $83.45. The stock has seen a notable decline, with a 52-week high of $107.90